Persons at risk for Alzheimer's disease (AD) demonstrate altered cortical activation measured by functional MRI (fMRI) years before symptoms of disease are expected. We used fMRI to study the differences in cortical activation between 13 women with a family history of AD and at least one apolipoprotein E4 allele, a risk factor for AD, and a control group of 11 women lacking both factors. Our primary goal was to assess how well the two groups are able to be statistically separated, a task which directly affects the performance of post hoc classification. The dimension of the dataset, however, precludes the use of ordinary classification methods. In this paper we show the superiority of using Oriented Partial Least Squares (OrPLS) to accomplish the classification in the presence of this dimensionality problem. We are able to reduce the misclassification rates on the standardized fMRI data from an average of about 48% for PCA, to an average of 27% for PLS, and then to perfect classification for OrPLS. Copyright ß 2008 John Wiley & Sons, Ltd.Keywords: Alzheimer's disease; functional magnetic resonance imaging; partial least squares; discriminant analysis
STATEMENT OF THE PROBLEMThe problem of distinguishing normal persons at risk of developing Alzheimer's disease, at a later time from other normal persons who will not, is intrinsically more difficult than distinguishing normal persons from patients with established dementia. This is because the underlying neuropathology is generally more advanced in persons with dementia than in persons who are normal but who will later become demented. This more advanced neuropathology causes greater alterations in the function of large-scale neuronal networks, and greater structural changes, e.g., loss of brain volume or atrophy, that are more easily detected using the imaging methods available today [1].Normal persons at risk for Alzheimer's disease (AD) demonstrate altered cortical activation measured by functional MRI (fMRI) years before symptoms of the disease are expected. We used fMRI to study the differences in cortical activation between 13 women with a family history of AD and at least one apolipoprotein E4 allele, a risk factor for AD, and a control group of 11 women lacking both factors. Our principal goal was to assess the ability of fMRI to function as a biomarker for diagnosis in the carrier and non-carrier groups. This will allow us to ascertain how well the two groups can be separated based on the fMRI signal, and additionally which regions seem to contribute most to this separation. This separation is important because identifying normal persons who have significant brain functional alterations implies that they already manifest early changes in neuronal network function, perhaps in compensation for subtle underlying AD neuropathology, even though these persons are still functioning and behaving normally. These persons represent the best candidates for preventive treatment aimed at altering the course of AD (disease-modifying treatment).The original study on this ...